Poseida
PSTXPoseida Therapeutics Price (PSTX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
90,185,096
(25.3377)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Poseida Therapeutics, Inc.Currency: USD
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
9,768,000.00
+0% |
2,985,000.00
-69% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
31,238.00
+0% |
130,361,508.00
+417,217% |
64,703,000.00
-50% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 0.00 | 689,000.00 | 1,193,000.00 | 2,586,000.00 | 4,552,000.00 | 5,172,000.00 | 156,772,000.00 | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
9,768,000.00
+0% |
2,985,000.00
-69% |
-689,000.00
-123% |
-1,193,000.00
+73% |
-2,586,000.00
+117% |
-4,520,762.00
+75% |
125,189,508.00
-2,869% |
-92,069,000.00
-174% |
|||||||||||
| Gross Profit Ratio | (1.00%) | (1.00%) | (0.00%) | (0.00%) | (0.00%) | (-144.72%) | (0.96%) | (-1.42%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 9,864,000.00 | 19,099,000.00 | 30,883,000.00 | 60,393,000.00 | 103,520.00 | 136,734.00 | 152,899,000.00 | 156,772,000.00 | |||||||||||
| General and Administrative | 5,353,000.00 | 5,479,000.00 | 9,674,000.00 | 18,457,000.00 | 23,029.00 | 35,915.00 | 37,539,000.00 | 37,435,000.00 | |||||||||||
| Selling, General & Admin... | 5,133,000.00 | 5,479,000.00 | 9,674,000.00 | 18,457,000.00 | 23,029.00 | 35,915.00 | 37,539,000.00 | 37,435,000.00 | |||||||||||
| Selling & Marketing Exp... | -220,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Depreciation and Amortiz... | 220,000.00 | 676,000.00 | 689,000.00 | 1,193,000.00 | 2,586,000.00 | 4,552,000.00 | 5,172,000.00 | 5,614,000.00 | |||||||||||
| Other Expenses | 0.00 | 37,000.00 | -821,000.00 | 2,559,000.00 | 280.00 | 19,795.00 | 2,858,000.00 | 0.00 | |||||||||||
| Total Operating Expenses | 14,997,000.00 | 24,578,000.00 | 40,557,000.00 | 78,850,000.00 | 126,549.00 | 172,649.00 | 190,438,000.00 | 194,207,000.00 | |||||||||||
| Cost and Exponses | 15,217,000.00 | 24,578,000.00 | 40,557,000.00 | 78,850,000.00 | 126,549.00 | 172,649.00 | 190,438,000.00 | 179,354,999.00 | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-5,449,000.00
+0% |
-19,668,000.00
+261% |
-41,989,000.00
+113% |
-85,533,000.00
+104% |
-126,549.00
-100% |
-141,411.00
+12% |
-59,946,000.00
+42,291% |
-129,504,000.00
+116% |
|||||||||||
| Operating Income Ratio | (-0.56%) | (-6.59%) | (0.00%) | (0.00%) | (0.00%) | (-4.53%) | (-0.46%) | (-2.00%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 0.00 | 0.00 | 1,553,000.00 | 3,506,000.00 | 3,358,000.00 | 6,370,000.00 | 0.00 | |||||||||||
| Interest Expenses | 0.00 | 558,000.00 | 1,796,000.00 | 3,553,000.00 | 3,506.00 | 3,358.00 | 6,370,000.00 | 8,671,000.00 | |||||||||||
| Total Other Income/Exp... | 109,000.00 | 1,404,000.00 | -2,617,000.00 | -7,677,000.00 | -129,648,451.00 | 16,437,000.00 | -3,512,000.00 | 6,181,000.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -5,120,000.00 | -20,880,000.00 | -45,121,000.00 | -91,681,000.00 | -145,483,000.00 | -117,064,000.00 | -54,774,000.00 | -109,038,000.00 | |||||||||||
| EBITDA ratio | (-0.54%) | (-6.99%) | (0.00%) | (0.00%) | (0.00%) | (-3.89%) | (-0.44%) | (-1.69%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -5,340,000.00 | -20,189,000.00 | -44,606,000.00 | -86,527,000.00 | -129,775.00 | -124,974.00 | -63,458,000.00 | -123,323,000.00 | |||||||||||
| Income Before Tax Ratio | (-0.55%) | (-6.76%) | (0.00%) | (0.00%) | (0.00%) | (-4.00%) | (-0.49%) | (-1.91%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -765,000.00 | -527,000.00 | -202,000.00 | 6,112,000.00 | -2,582,214.00 | -4,528,847.00 | 544,000.00 | 107,000.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -4,575,000.00
+0% |
-19,662,000.00
+330% |
-44,404,000.00
+126% |
-92,639,000.00
+109% |
2,452,439.00
-103% |
4,403,873.00
+80% |
-64,002,000.00
-1,553% |
-123,430,000.00
+93% |
|||||||||||
| Net Income Ratio | (-0.47%) | (-6.59%) | (0.00%) | (0.00%) | (0.00%) | (140.98%) | (-0.49%) | (-1.91%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.08 | -0.49 | -1.24 | -2.33 | 0.07 | 0.07 | -0.89 | -1.37 | |||||||||||
| Diluted EPS | -0.08 | -0.49 | -1.24 | -2.33 | 0.07 | 0.07 | -0.89 | -1.37 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 59,315,886.00 | 39,733,866.00 | 35,930,061.00 | 39,733,866.00 | 35,996,901.00 | 62,176,150.00 | 71,912,358.00 | 90,185,096.00 | |||||||||||
| Diluted Share Outstanding | 59,315,886.00 | 39,733,866.00 | 35,930,061.00 | 39,733,866.00 | 35,996,901.00 | 62,235,940.00 | 71,953,703.00 | 90,185,096.00 | |||||||||||